Dr. Hal Skopicki, MD

Dr. Skopicki practices at Stony Brook Internists in Hauppauge, New York.

Dr. Skopicki's NPI, 1346264553, was assigned on July 27, 2006. Dr. Skopicki graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990. Dr. Skopicki holds New York license 206554.

Dr. Skopicki's primary practice is Stony Brook Internists, at 200 Motor Pkwy, Hauppauge, NY 11788 in Suffolk County. The practice phone is (631) 444-2448.

Dr. Skopicki's primary practice is Stony Brook Internists in Hauppauge, New York. Dr. Skopicki is also affiliated with Stony Brook University Hospital. The medical group on file is Stony Brook Internists. Dmand AI also links Dr. Skopicki to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skopicki practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Skopicki's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Skopicki is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Skopicki's licenses on file in 2 states: New York and Massachusetts.

Dmand AI lists cardiomyopathy, congestive heart failure and heart failure among the conditions Dr. Skopicki treats.

CMS data shows 560 Medicare services from Dr. Skopicki across 8 procedure codes in 2024, for 231 Medicare patients. Medicare paid $54,846 for them.

CMS counts 231 Medicare patients who saw Dr. Skopicki in 2024. The largest group is 75 to 84, with 91 patients. 75% of them have heart failure, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Skopicki's median patient age at 66, with 32% women.

In 2024, Dr. Skopicki wrote 368 Medicare Part D claims for 88 patients. 66% of them were for generic drugs. CMS names the drug for 271 of them, across 7 drugs with 11 or more claims each, at $174,368 in total drug cost. In 2023, CMS named 293 claims across 12 drugs.

Dr. Skopicki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 48 papers to Dr. Skopicki, published from 2013 to 2024. 2020 was the busiest year, with 9. The most frequent topics are Heart Failure, Stroke Volume and Transcatheter Aortic Valve Replacement. Dr. Skopicki has published most often in Circ Heart Fail. Dr. Skopicki's most frequent co-authors are Smadar Kort, MD, Robert T. Pyo, MD and Ting-Yu Wang, MD.

Dmand AI links Dr. Skopicki to 13 clinical trials, 3 of them phase 2 studies. Conditions studied include Heart Failure, Heart Diseases and Anemia, Iron-Deficiency. Duke University sponsors the most, 4.

CMS Open Payments shows 179 general payments to Dr. Skopicki from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 91% of the total. Novartis Pharmaceuticals Corporation paid the most, $128,995.

Dmand AI lists 5 awards for Dr. Skopicki.

Dr. Skopicki graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990. Dr. Skopicki is a member of ACC, AHA and AMA.

Dr. Skopicki is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.